Evidence map›Paper›PMID 33441889›Full record

ArticleScientific reports2021

Fast 3 T nigral hyperintensity magnetic resonance imaging in Parkinson's disease.

Gabriella Hernadi, David Pinter, Szilvia Anett Nagy, Gergely Orsi, Samuel Komoly, Jozsef Janszky, Norbert Kovacs, Gabor Perlaki

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Gabriella HernadiPecs Diagnostic Centre, Pecs, Hungary.
David PinterDepartment of Neurology, Medical School, University of Pecs, Pecs, Hungary.
Szilvia Anett NagyPecs Diagnostic Centre, Pecs, Hungary.
Gergely OrsiPecs Diagnostic Centre, Pecs, Hungary.
Samuel KomolyDepartment of Neurology, Medical School, University of Pecs, Pecs, Hungary.
Jozsef JanszkyDepartment of Neurology, Medical School, University of Pecs, Pecs, Hungary.
Norbert KovacsDepartment of Neurology, Medical School, University of Pecs, Pecs, Hungary.
Gabor PerlakiPecs Diagnostic Centre, Pecs, Hungary. petzinger.gabor@gmail.com.
University of Pecs · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The absence of nigral hyperintensity is a promising MR marker for Parkinson's disease (PD), but its small size imposes limitations on its routine use. Our aim was to compare Multi Echo Data Image Combination (MEDIC), segmented echo-planar imaging (EPISEG) and fluid-attenuated inversion recovery (FLAIR) sequences, as well as both magnitude (MAG) and susceptibility-weighted imaging (SWI) reconstructions of single-echo gradient echo for nigral hyperintensity imaging. Twenty-five healthy and twenty PD subjects were included. Sensitivity to motion artefacts, confidence of the radiologist in interpretation, rate of nondiagnostic scans and diagnostic accuracy were assessed. EPISEG was less motion-sensitive than MEDIC, MAG, and SWI, while FLAIR was less motion-sensitive than MAG and SWI. The reviewers were more confident when using EPISEG compared to any other techniques and MEDIC was superior to FLAIR. The proportions of nondiagnostic scans were lower for EPISEG than for other sequences. The best diagnostic performance was achieved for EPISEG (sensitivity = 65%, specificity = 96%). Using EPISEG, the absence of nigral hyperintensity in PD was associated with higher Hoehn-Yahr stage and MDS-UPDRS II + III. Nigral hyperintensity may be intact at the very early stages of PD. The promising properties of EPISEG may help the transfer of nigral hyperintensity imaging into daily clinical practice.

Indexed as

AdultAgedBiomarkersEcho-Planar ImagingFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedMotionParkinson DiseaseSubstantia NigraBiomarkers

Identifiers

PMID33441889
PMCPMC7806895
OpenAlexW3120934432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.